EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Left Atrial Appendage Closure in Patients Refusing Oral Anticoagulation: The LAAC‐REFUSAL Study

Roberto Galea iD, Tommaso Bini iD, Kasper Korsholm iD, Alexander Sedaghat iD, Adel Aminian iD, Vivian Vij iD, Juan Perich Krsnik, Konstantina Chalkou iD, Georgios Siontis iD, Laurent Roten iD, Jens Erik Nielsen-Kudsk iD, Lorenz Räber iD

Journal of the American Heart Association · 07.10.2025 · 14 (19)

DOI: 10.1161/jaha.124.040404 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of the American Heart Association, erschienen am 07.10.2025. Verfasst von Roberto Galea und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology Inselspital, Bern University Hospital, University of Bern Switzerland. Hauptthemen laut MEDLINE: Atrial Appendage, Atrial Fibrillation, Anticoagulants, Stroke. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The benefit of left atrial appendage closure (LAAC) in patients refusing oral anticoagulation (OAC) despite medical recommendations is unknown. We aim to assess the efficacy and the safety of LAAC in patients refusing OAC.

Methods

Data on consecutive patients with atrial fibrillation undergoing percutaneous LAAC between 2009 and 2022 in 4 European centers were collected and patients undergoing LAAC due to refusal of OAC (refusal group) were compared with patients receiving LAAC for more established indications (control group). The primary end point of the study was the composite of cardiovascular death, stroke, or systemic embolism. The secondary end points included technical success and procedural complications. Events during follow‐up were compared with those predicted by CHA2DS2VASC and hypertension, abnormal renal/liver function, stroke, bleeding history or predisposition, labile International Normalized Ratio, elderly, drugs/alcohol concomitantly (HASBLED) score risks.

Results

Of the 2649 patients submitted to LAAC, 119 were performed due to OAC refusal (4.5%). Two‐hundred‐thirty‐eight (8.9%) control patients were identified. Refusal as compared with the control group included younger and lower‐risk patients. At 3 years, the primary end point was significantly lower (4.2% versus 17.2%; adjusted hazard ratio: 0.37; 95% CI: 0.14–0.99; P =0.048) in the refusal in respect to the control group. Technical success and procedural complications were similar between groups. In the refusal group, the annual rate of thromboembolic events and major bleedings were 2.3% and 1.9%, respectively, corresponding to 62% and 47% risk reductions as compared with the rates expected by risk scores.

Conclusions

In this multicenter cohort of consecutive patients with atrial fibrillation submitted to LAAC, OAC refusal appeared as an infrequent indication. In this subgroup, LAAC was confirmed to be feasible and safe. The ischemic outcomes rates at 3 years are promising. Further studies are needed to better understand the potential effects of preferring LAAC over OAC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial AppendageAtrial FibrillationAnticoagulantsStrokeTreatment RefusalCardiac CatheterizationHumansMaleFemaleAgedAdministration, OralAged, 80 and overTreatment OutcomeEuropeMiddle AgedRisk AssessmentRisk FactorsRetrospective StudiesLeft Atrial Appendage Closure

Stichwörter der Autor:innen

adherenceatrial fibrillationintoleranceleft atrial appendage closurenon‐complianceoral anticoagulation refusal

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Department of Cardiology Inselspital, Bern University Hospital, University of Bern Switzerland.
  • Department of Cardiology Aarhus University Hospital Aarhus Denmark.
  • Department of Cardiology University Hospital Bonn Bonn Germany.
  • Department of Cardiology Centre Hospitalier Universitaire de Charleroi Charleroi Belgium.
  • Department of Clinical Research University of Bern Switzerland.

ORCID-Profile: Roberto Galea, Tommaso Bini, Kasper Korsholm, Alexander Sedaghat, Adel Aminian, Vivian Vij, Konstantina Chalkou, Georgios Siontis, Laurent Roten, Jens Erik Nielsen-Kudsk, Lorenz Räber

Zitieren

APA

Galea, R., Bini, T., Korsholm, K., Sedaghat, A., Aminian, A., Vij, V., Perich Krsnik, J., Chalkou, K., Siontis, G., Roten, L., Nielsen-Kudsk, J. E., & Räber, L. (2025). Left Atrial Appendage Closure in Patients Refusing Oral Anticoagulation: The LAAC‐REFUSAL Study. Journal of the American Heart Association, 14(19). https://doi.org/10.1161/jaha.124.040404

Vancouver

Galea R, Bini T, Korsholm K, Sedaghat A, Aminian A, Vij V, et al. Left Atrial Appendage Closure in Patients Refusing Oral Anticoagulation: The LAAC‐REFUSAL Study. Journal of the American Heart Association. 2025;14(19). doi:10.1161/jaha.124.040404

BibTeX
@article{Galea2025,
  author = {Galea, Roberto and Bini, Tommaso and Korsholm, Kasper and Sedaghat, Alexander and Aminian, Adel and Vij, Vivian and Perich Krsnik, Juan and Chalkou, Konstantina and Siontis, Georgios and Roten, Laurent and Nielsen-Kudsk, Jens Erik and Räber, Lorenz},
  title = {Left Atrial Appendage Closure in Patients Refusing Oral Anticoagulation: The LAAC‐REFUSAL Study},
  journal = {Journal of the American Heart Association},
  year = {2025},
  volume = {14},
  number = {19},
  doi = {10.1161/jaha.124.040404}
}
Kostenlos starten →